Search

Displaying results 8551 - 8560 of 10000 in total
  1. Drug

    Valanafusp alfa

    go.drugbank.com/drugs/DB15336
    Investigational

    Valanafusp alfa is under investigation in clinical trial NCT03071341 (Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I).

  2. Drug

    JNJ-27548547

    go.drugbank.com/drugs/DB15372
    Investigational

    JNJ-27548547 is under investigation in clinical trial NCT01705002 (Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients With Solid Tumors.).

  3. Drug

    BMS-754807

    go.drugbank.com/drugs/DB15399
    Investigational

    BMS-754807 is under investigation in clinical trial NCT00908024 (Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors).

  4. Drug

    Technetium Tc-99m epratuzumab

    go.drugbank.com/drugs/DB15452
    Experimental

    Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).

  5. Drug

    WGc-0201

    go.drugbank.com/drugs/DB22819
    Investigational

    WGc-0201 is under investigation in clinical trial NCT07077369 (WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy).

  6. Drug

    Plazinemdor

    go.drugbank.com/drugs/DB21493
    Investigational

    Plazinemdor is a small molecule drug. Plazinemdor is under investigation in clinical trial NCT04306146 (Study of CAD-9303 in Subjects With Schizophrenia).

  7. Drug

    Ulixertinib

    go.drugbank.com/drugs/DB13930
    Investigational

    It is currently in clinical trials for the treatment of a wide range of tumors. … Ulixertinib is a a novel, reversible, ATP-competitive ERK1/2 inhibitor with high potency and ERK1/2 selectivity [A31474].

  8. Drug

    Ontuxizumab

    go.drugbank.com/drugs/DB16270
    Investigational

    It is under investigation in clinical trial NCT01574716 (Sarcoma Study of Morab-004 Utilization: Research and Clinical Evaluation). … Ontuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1).

  9. Drug

    Denbufylline

    go.drugbank.com/drugs/DB19482
    Experimental

    Denbufylline is a small molecule drug. The usage of the INN stem '-fylline' in the name indicates that Denbufylline is a N-methylated xanthine derivative.

  10. Drug

    Indolidan

    go.drugbank.com/drugs/DB19499
    Experimental

    Indolidan is a small molecule drug. The usage of the INN stem '-dan' in the name indicates that Indolidan is a cardiac stimulant, pimobendan derivative.